Outset Medical Inc.

OM | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.16

+$0.04 (+1.28%)

Sep 22, 2026, 9:55 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.28%

(1D)

Rating

Updated: Aug 11, 2026

30.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $58.58M

1D Range

3.13 3.19

52W Range

3 16.16

Valuation (TTM)

PE -0.76

PB 0.60

EV/EBITDA 1.47

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target $14

Cash Flow

FCF Yield -89.5%

SBC Adj. FCF Yield -122.0%

SBC Impact -36.2%

Margins

Gross Margin 41.8%

Operating Margin -56.1%

FCF Margin -44.0%

Growth (CAGR)

Revenue 3Y | 5Y -3.0% | 8.3%

Dil EPS 3Y | 5Y 56.2% | -19.1%

FCF 3Y | 5Y 50.9% | 23.7%

Returns

ROA -30.6%

ROE -62.3%

ROIC -32.8%

Financial Health

Net Cash

$140.39M

Current Ratio 5.19

Interest Coverage -4.81

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to del...

Sector Healthcare

Industry Medical - Devices

Employees 310

IPO Date Sep 14, 2020

Website www.outsetmedical.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+153.16%

Buy (2)

Hold (1)

Sell (0)

Analyst Details ➞